Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide

We provide evidence that arsenic trioxide (As(2)O(3)) targets the BCR-ABL oncoprotein via a novel mechanism involving p62/SQSTM1-mediated localization of the oncoprotein to the autolysosomes and subsequent degradation mediated by the protease cathepsin B. Our studies demonstrate that inhibitors of a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Goussetis, Dennis J., Gounaris, Elias, Wu, Edward J., Vakana, Eliza, Sharma, Bhumika, Bogyo, Matthew, Altman, Jessica K., Platanias, Leonidas C.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Myeloid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3482863/
https://ncbi.nlm.nih.gov/pubmed/22898604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-01-402578
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars